384 publications
Name | Date | Type | Actions |
---|---|---|---|
Monthly information regarding the total number of voting rights and shares making of the share capital - October 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
17/11/2014 | Voting rights | |
Q3 2014 sales up 11.0% The Vétoquinol Group reported Q3 2014 sales of €82.2 million, up 11.0% compared to the same period last year (up 11.1% at constant exchange rates). |
23/10/2014 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
09/10/2014 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
18/09/2014 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
18/09/2014 | Voting rights | |
Solid growth in Q2 2014: 8.8% first half net income up 4.2% At its July 30, 2014 meeting, the Vétoquinol S.A. Board of Directors reviewed the Group results and approved the financial statements for the first six months of 2014. |
31/07/2014 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - June 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/07/2014 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - May 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
15/06/2014 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - April 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
15/05/2014 | Voting rights | |
Vétoquinol and Bioniche Life Sciences Inc. close sale of Bioniche Animal Health business Lure, France and Belleville, Ontario, Canada, April 16, 2014 - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced the closing of the sale of Bioniche’s Animal Health business to Vétoquinol. The two companies announced the signing of a share purchase agreement in February that was subject to the approval of Bioniche shareholders. At a Special Meeting of Shareholders held yesterday, 97.4% of the Shares that were voted were in favour of the transaction. |
16/04/2014 | Public releases | |
Reference products up 2.2% in Q1 2014 Lure, April 16, 2013 – Vétoquinol posted Q1 2013 sales of €75.5 million, compared to €77.0 million for the first quarter of 2012. Like-for-like sales amounted to €76.0 million, compared to €77.0 million in Q1 2012. |
15/04/2014 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - mars 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
15/04/2014 | Voting rights | |
Vétoquinol is eligible for new PEA-PME funds Lure (France), April 2, 2014 – Vétoquinol confirms that it qualifies for the PEA-PME investment product in accordance with Decree n°. 2014-283 on 4 March 2014 reflecting the application of Article 70 of 2014 finance law (n°. 2013-1278 dated 29 December 2013) which set the conditions of companies’ eligibility for the PEA-PME |
02/04/2014 | Public releases | |
2013 growth driven by reference products Lure (France), March 12, 2014 – At its March 11, 2014 meeting, the Vétoquinol SA board of directors reviewed the Group results and approved the 2013 financial statements. |
12/03/2014 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - February 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
12/03/2014 | Voting rights | |
Vétoquinol to acquire the animal health business of Bioniche Life Sciences Inc. LURE, FRANCE and BELLEVILLE, ONTARIO, CANADA, February 27, 2014 - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche’s Animal Health business for the cash purchase price of CAD$61 million. |
27/02/2014 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
17/02/2014 | Voting rights | |
7.8% organic growth in Q4 2013 The Vétoquinol Group posted Q4 2013 sales of €80.1 million, up +7.8% like for like from Q4 2012. |
23/01/2014 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - December 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
17/01/2014 | Voting rights | |
Jean-Yves RAVINET appointed Group Chief Operating Officer Lure (France), January 7, 2014 – The Vétoquinol Group announces the appointment of Jean-Yves Ravinet as Group Chief Operating Officer. |
07/01/2014 | Public releases | |
Vétoquinol continues to launch reference products Lure (France), December 16, 2013 – In line with its strategy of developing products targeting fast-growing markets, the Vétoquinol Group expands its Flexadin® range world-wide and launches Zylkène® in the United States. |
16/12/2013 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/12/2013 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - October 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
10/12/2013 | Voting rights | |
2013 3rd quarter sales show organic growth Vétoquinol generated sales of €74.0 million in the 3rd quarter of 2013, a drop of 0.1% based on reported data, and a 4.4% increase at constant exchange rates. |
24/10/2013 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
10/10/2013 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - august 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
18/09/2013 | Voting rights | |
The reference products demonstrate solid growth Lure (France), August 29, 2013 – At its meeting on August 27, 2013, the Vétoquinol S.A. Board of Directors reviewed the Group’s results, and approved the financial statements for the first six months of 2013. |
29/08/2013 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - july 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
23/08/2013 | Voting rights | |
Q2 2013 sales Vétoquinol posted Q2 2013 sales of €70 million, up 0.3% on reported figures and up 1.4% like for like. |
16/07/2013 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - june 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/07/2013 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - mai 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/06/2013 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - april 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/05/2013 | Voting rights | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2012 (french version) The registration document of Vétoquinol relative to fiscal year 2012, including the annual financial report relative to fiscal year 2012, was registered with the Autorité des marchés financiers (“the AMF”) on April 15th, 2013. |
16/04/2013 | Public releases | |
Q1 2013 sales Lure, April 16, 2013 – Vétoquinol posted Q1 2013 sales of €75.5 million, compared to €77.0 million for the first quarter of 2012. Like-for-like sales amounted to €76.0 million, compared to €77.0 million in Q1 2012. |
16/04/2013 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - march 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
12/04/2013 | Voting rights | |
2012, return to growth Lure, March 26, 2013 – The Vétoquinol Board meeting of March 7, 2013 reviewed the Group's business and approved the 2012 financial statements. |
26/03/2013 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - february 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
12/03/2013 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - january 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
12/02/2013 | Voting rights | |
2012 sales up 5.0% Lure (France), January 24, 2013 – Vétoquinol posted 2012 sales of €298.3 million, up 5.0% compared to the previous year. At constant exchange rates, annual sales increased by 3.0%. |
24/01/2013 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - december 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/01/2013 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - november 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
10/12/2012 | Voting rights | |
Forcyl® - a booming brand Lure (France), November 14, 2012 – Vétoquinol receives a new indication for its Forcyl® product, designed for cattle, and a new market authorization for Forcyl® Swine for pigs. |
14/11/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - October 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
14/11/2012 | Voting rights | |
Sales momentum continues in Q3 Vétoquinol posted sales of €220.9 million for the first 9 months of 2012, up 6.2% compared to the same period last year. |
25/10/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - September2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/10/2012 | Voting rights | |
Vétoquinol purchases ORSCO laboratoire vétérinaire Lure (France), September 25, 2012 – Vétoquinol announces the purchase of the entire equity of Orsco Laboratoire Vétérinaire. |
25/09/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/09/2012 | Voting rights | |
Vétoquinol returns to growth Lure (France), 29 August 2012 – At its 29 August 2012 meeting, the Vétoquinol S.A. board of directors reviewed the Group results and approved the financial statements for the first six months of 2012. |
29/08/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
27/08/2012 | Voting rights | |
Solid first half 2012 Sales First half 2012 sales reached €146.8 million, up 5.1% over first half 2011. |
17/07/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - June 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
16/07/2012 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - May 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
18/06/2012 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - April 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
16/05/2012 | Voting rights | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2011 (french version) The registration document of Vétoquinol relative to fiscal year 2011, including the annual financial report relative to fiscal year 2011, was registered with the Autorité des marchés financiers (“the AMF”) on April 20th, 2012. |
23/04/2012 | Public releases | |
Strong Revenue growth in the first quarter of 2012 Vétoquinol achieved Q1 2012 sales of €77.0 million, up 15.9% compared to Q1 2011. |
20/04/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - March 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/04/2012 | Voting rights | |
2011 annual earnings Lure (France), April 03, 2012 – The Vétoquinol Board Meeting of March 26, 2012 has reviewed the Group’s business and approved the 2011 financial statements. |
03/04/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - February2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
13/03/2012 | Voting rights | |
Flevox® the new parasiticide for dogs and cats Lure (France), 14 February 2012 – Vétoquinol launches Flevox®, the latest addition to its range of parasiticides. The new drug is based on fipronil, the molecule par excellence in the treatment of tick and flea infestations in pets. |
14/02/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2012 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
06/02/2012 | Voting rights | |
2011, a year of transition Lure (France), January 24, 2012 – In 2011, Vétoquinol achieved sales of €284.1 million, 0.7% up on the previous year and stable on a like-for-like basis. |
24/01/2012 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - December2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
13/01/2012 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - November2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
14/12/2011 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - October 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
09/11/2011 | Voting rights | |
Q3 2011 Sales Vétoquinol achieved Q3 2011 sales of €68.4 million, in line with the previous year. |
25/10/2011 | Public releases | |
Jacques du Puy appointed Vétoquinol Managing Director Lure (France), October 12, 2011 – The Vétoquinol Group announces the appointment |
12/10/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/10/2011 | Voting rights | |
Forcyl®: european launch of new drug Lure (France), September 29, 2011 – Vétoquinol announces the European launch of Forcyl®, a new drug based on 16% concentrated marbofloxacin allowing the treatment of cattle respiratory infections with a single injection. |
29/09/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/09/2011 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/09/2011 | Voting rights | |
Vétoquinol continues to develop its product ranges and enters the brazilian market Lure (France), August 30, 2011 – The Vetoquinol Board Meeting of August 29, 2011 reviewed the Group’s business and approved the financial statements for the first half 2011. |
30/08/2011 | Public releases | |
International expansion and new product launches Lure (France), July 19, 2011 – Vétoquinol Group sales rose to €139.7 million in the first six months of 2011. |
19/07/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - June 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/07/2011 | Voting rights | |
European launch of new Nsaid Cimalgex® Lure (France), June 14, 2011 – Vetoquinol announces the European launch of CIMALGEX®, a new treatment for pain and inflammation in dogs. |
14/06/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - May 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/06/2011 | Voting rights | |
VÉTOQUINOL enters the brazilian Market Lure (France), June 7, 2011 – Vetoquinol announces the acquisition of 100% of the equity of Farmagricola SA in Brazil. |
07/06/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - April 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
09/05/2011 | Voting rights | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2010 (french version) The registration document of Vétoquinol relative to fiscal year 2010, including the annual financial report relative to fiscal year 2010, was registered with the Autorité des marchés financiers (“the AMF”) on April 18th, 2011. |
27/04/2011 | Public releases | |
Net Sales rise 3% to €66.4 Million in the first Quarter of 2011 The Vétoquinol group reported a 3.0% rise in first quarter 2011 net sales to €66.4 million, compared to the same period last year. |
19/04/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - March 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
12/04/2011 | Voting rights | |
2010 annual earnings Lure (France), April 4, 2011 – Vétoquinol’s Board of Directors, meeting on March 18, 2011, has reviewed the Group’s business and approved its 2010 financial statements. |
04/04/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - February2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/03/2011 | Voting rights | |
Redemption of tranche B bonds Lure, 28 February 2011 – Vétoquinol S.A. has announced the redemption of the 58,927 tranche B bonds reaching maturity on 27 February 2011, by their conversion into common shares. |
28/02/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
09/02/2011 | Voting rights | |
2010 Revenues grow 11.8%, driven by organic growth The Vétoquinol Group reports sustained sales growth driven by its “hybrid” business model, supported by a sound level of organic growth. |
25/01/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - December 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
10/01/2011 | Voting rights | |
Vétoquinol markets CEFTIOCYL® and KEFLORIL® two new injectable antibiotics for livestock Lure, December 15, 2010 – In line with recent announcements, Vétoquinol is |
15/12/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/12/2010 | Voting rights | |
November 30, 2010 (Lure, France) – Vétoquinol has appointed Régis Vimal du Monteil as |
30/11/2010 | Public releases | |
Vétoquinol registers its injectable Marbocyl® 2% and Marbocyl® 10% antibiotics in Japan November 18, 2010 (Lure, France) – Vétoquinol has just obtained Marketing |
18/11/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - October2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
10/11/2010 | Voting rights | |
Strong Sales in the 3rd Quarter of 2010 Vétoquinol’s revenues for the third quarter of 2010 rose by 10.8%. This healthy rate of growth was attributable mainly to strong performance in the Group’s strategic regions and therapeutic segments. |
19/10/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/10/2010 | Voting rights | |
Mise à disposition ou de consultation du rapport financier semestriel 2010 (french) Le Rapport financier semestriel 2010 de Vétoquinol peut être consulté ou téléchargé sur |
17/09/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
06/09/2010 | Voting rights | |
Strong Results in the first half of 2010 The Board of Directors of Vétoquinol, meeting on August 30, reviewed the group’s business and approved its interim 2010 financial statements. |
30/08/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
17/08/2010 | Voting rights | |
Continued Sales Growth in the second Quarter of 2010 Vétoquinol recorded strong sales growth (+15.1%) in the first six months of 2010, driven mainly by an increase in organic growth. |
16/07/2010 | Public releases | |
BOREVE-D: Vétoquinol is participating in a project to raise awareness of the need to treat pain in cattle June 30, 2010 (Lure, France) – Vétoquinol, in collaboration with two other veterinary laboratories, is participating in a project organised by the Syndicat de l’Industrie du Médicament Vétérinaire (SIMV) to raise awareness of the need to treat pain in cattle. |
30/06/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - May 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
04/06/2010 | Voting rights |